These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31197859)

  • 1. Exploring the systematic effect of N-substituted PxxP motifs on peptoid affinity to ARHGEF5/TIM SH3 domain and its relationship with ARHGEF5/TIM activation.
    Fu Y; He P; Zhou Y; Huang S; Liang L; Liu S
    Proteins; 2019 Nov; 87(11):979-991. PubMed ID: 31197859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The auto-inhibitory state of Rho guanine nucleotide exchange factor ARHGEF5/TIM can be relieved by targeting its SH3 domain with rationally designed peptide aptamers.
    He P; Tan DL; Liu HX; Lv FL; Wu W
    Biochimie; 2015 Apr; 111():10-8. PubMed ID: 25645980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
    Han S; Liu Q; Wang F; Yuan Z
    J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
    Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular design and optimization of hepatic cancer SLP76-derived PLCγ1 SH3-binding peptide with the systematic N-substitution of peptide PXXP motif.
    Tang W; Zhao Z; Wang C; Ye T; Yang B
    J Mol Recognit; 2019 Dec; 32(12):e2806. PubMed ID: 31397025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-substituting perturbation on the interaction affinity and recognition specificity between rheumatic immune-related Abl SH3 domain and its peptoid ligands.
    Tang X; Chen J; Cai J; Wang Q
    J Mol Graph Model; 2023 Dec; 125():108601. PubMed ID: 37607432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting rho guanine nucleotide exchange factor ARHGEF5/TIM with auto-inhibitory peptides in human breast cancer.
    Huang O; Wu D; Xie F; Lin L; Wang X; Jiang M; Li Y; Chen W; Shen K; Hu X
    Amino Acids; 2015 Jun; 47(6):1239-46. PubMed ID: 25743165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics simulation, energetics calculation and experimental analysis of the intermolecular interaction between human neonatal ABL SH3 domain and its
    Zhao S; Shen L; Wang Q; Lu W
    J Biomol Struct Dyn; 2024; 42(22):12637-12644. PubMed ID: 37909467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving SH3 domain ligand selectivity using a non-natural scaffold.
    Nguyen JT; Porter M; Amoui M; Miller WT; Zuckermann RN; Lim WA
    Chem Biol; 2000 Jul; 7(7):463-73. PubMed ID: 10903934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why the first self-binding peptide of human
    Zhou P; Yan F; Miao Q; Chen Z; Wang H
    J Biomol Struct Dyn; 2021 Jan; 39(1):310-318. PubMed ID: 31872783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Binding of Syndapin SH3 Domain to Dynamin Proline-rich Domain Involves Short and Long Distance Elements.
    Luo L; Xue J; Kwan A; Gamsjaeger R; Wielens J; von Kleist L; Cubeddu L; Guo Z; Stow JL; Parker MW; Mackay JP; Robinson PJ
    J Biol Chem; 2016 Apr; 291(18):9411-24. PubMed ID: 26893375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
    Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
    Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.
    Kami K; Takeya R; Sumimoto H; Kohda D
    EMBO J; 2002 Aug; 21(16):4268-76. PubMed ID: 12169629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of polyproline II regions derived from the proline-rich nuclear receptor coactivators PNRC and PNRC2: new insights for ERα coactivator interactions.
    Byrne C; Miclet E; Broutin I; Gallo D; Pelekanou V; Kampa M; Castanas E; Leclercq G; Jacquot Y
    Chirality; 2013 Oct; 25(10):628-42. PubMed ID: 23925889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
    Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
    J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the C-terminal SH3 domain and N-terminal tyrosine phosphorylation in regulation of Tim and related Dbl-family proteins.
    Yohe ME; Rossman K; Sondek J
    Biochemistry; 2008 Jul; 47(26):6827-39. PubMed ID: 18537266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
    Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
    Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the thermodynamics of binding of an SH3 domain to proline-rich peptides using a chimeric fusion protein.
    Candel AM; van Nuland NA; Martin-Sierra FM; Martinez JC; Conejero-Lara F
    J Mol Biol; 2008 Mar; 377(1):117-35. PubMed ID: 18234212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of PxxDY motif recognition in SH3 binding.
    Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
    J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.